A newly commissioned study conducted by Milliman in the traditional Medicare population found that nearly 70% of anxiety and insomnia patients are treated with prescription drugs only, and less than 10% receive the psychotherapy, which is indicated as first-line care. This webinar will discuss the study findings and offer perspectives on moving beyond medication to address critical gaps in behavioral health care.
Bringing together perspectives from psychology, psychiatry and health economics, this webinar will examine current treatment patterns among traditional Medicare beneficiaries, gaps in current reimbursement policies and the potential of digital treatments.
Submit the form to watch the replay
Watch the replay
Here’s our latest
The Impact of Caregiving on Mental Health: Supporting Employees and their Families
According to recent estimates, 1 in 5 US workers serve as family caregivers. Caring for loved ones while balancing workforce…
Both Sides of the Coin: Communicating the Impact of Mental Health Equity & ROI
With nearly half of adult Americans experiencing a clinical mental health issue over the past year, it’s clear we need…
Conversations with Colin: How digital therapeutics fit into the standard of care in mental health
Professor Colin Espie wears many hats: Co-Founder of Big Health, Oxford University Professor of Sleep Medicine, and world-renowned clinical psychologist….